You searched for: cancer
1 to 10 of 35 results
Show
results per page
Matched phrases in profile:
MPS and cancer prognosis, circulating fDNA, Sentinel Node biopsy trials Breast Cancer Audit and cancer registries… Is parathyroid hormone-related protein a sensitive serum marker in advanced breast cancer?… Whole Genome Sequencing in high-risk breast cancer patients.… Breast Cancer… University of Nottingham(UK) and Mayo Clinic (USA) Chairman, Foundation for Breast Cancer Care… Background: To compare already used serum markers in advanced breast cancer, namely erythrocyte…
Breast and Endocrine Surgeon, Mater Hospitals South Brisbane.
Previous Fellowships at University of Nottingham(UK) and Mayo Clinic (USA)
Chairman, Foundation for Breast Cancer Care
Senior Surgeon Breast Screen Qld Metro south Brisbane
Breast Cancer Quality Audit - >140,000 entries , identiying gaps in service delivery to Breast Cancer patients
Matched phrases in profile:
The LACE study is a clinical trial comparing two types of surgery for women with early-stage cancer… Cancer specialists are aware that not only the survival time but also the quality of life is a key… The value of serum CA125 for the development of virtual follow-up strategies for patients with epithelial ovarian cancer: A retrospective study… feMMe: Uterus-preserving treatment of endometrial cancer… Prophylactic surgery and breast cancer… levonorgestrel intrauterrine device (LNG-IUD) to treat endometrial cancer. The next two steps… Professor Obermair is the Director of Queensland Centre for Gynaecological Cancer Research (QCGC… Background: Serum CA125 is routinely used in the follow up of ovarian cancer. The objective of the…
Professor Obermair is the Director of Queensland Centre for Gynaecological Cancer Research (QCGC Research). He is a Professor of Gynaecological Oncology since 2007, a Senior Medical Officer at Royal Brisbane & Women’s Hospital and a Visiting Medical Officer at St Andrews War Memorial Hospital and …
Professor Obermair is an innovative and skilled gynaecologic oncologist, surgical teacher and consumer advocate. His international leadership and research impact was acknowledged in 2020 by the Australian community, when he was awarded an NHMRC Investigator Fellowship Level 2 (2021-25). The national …
Matched phrases in profile:
Therapeutic Opportunity in Cancers with Poor Survival… Complex neoantigen prediction in cancers… genome sequencing technologies in biomedical research. In particular large cancer research…
Research officer, Medical Genomics
QIMR Berghofer Medical Research Institute
My research addressed the challenges related to key genomic components in tumour-immune editing variation in cancers with poor survival and predicting the responses to cancer immunotherapies. Characterizing genomic determinants in underlying response and resistance to cancer immunotherapy. Through w …
Matched phrases in profile:
3D printing and biofabrication tissue engineering reconstruction surgery breast cancer quality… Intraoperative imprint cytology for breast cancer sentinel nodes: is it worth it?… Quality of life after breast cancer treatment through improved pathways of care… with small breast cancers (NHMRC Project Grant administered by the University of Sydney)… Breast cancer survival has improved incrementally at about 1% per annum for the last 30 years… Multidisciplinary breast cancer care… Cancer Institute (CBCI) and Program lead for the Breast Reconstruction at the Herston Biofabrication… cancer to 10 centres participating in the trial. Results: More than half of the 622 women (54%) were…
Owen Ung is a breast and endocrine surgeon, Director of the Metro North Comprehensive Breast Cancer Institute (CBCI) and Program lead for the Breast Reconstruction at the Herston Biofabrication Institute (HBI). He is a committed clinician, researcher and educator.
Affiliations:
Professor of Surger …
Refer to my Google Scholar profile
My recent clinical research interests involve improving pathways of care for women diagnosed with breast cancer. Through my clinical and research advocacy as Director of the CBCI we have introduced clinical innovation within a research framework, not existing in m …
Matched phrases in profile:
Using published datasets, and tissue donated by Brisbane breast cancer patients, we're trying to… Post-transcriptional regulation of the breast cancer susceptibility gene BRCA1 by Hu Antigen-R… Development of new theranostic agents for metastatic breast cancer surveillance and treatment… Molecular validation of autofluorescence and narrow band imaging of oral cancer resection margins… Most of the time, treatments for early breast cancer successfully prevent metastatic spread, but… Biomarkers of triple-negative breast cancer progression and response to therapy… cancer. Based at Brisbane’s Translational Research Institute, she was recruited by Mater Research… BRCA1 is a breast cancer susceptibility gene that is down-regulated in the majority of cases of…
Dr Jodi Saunus is a senior fellow who specialises in translational research on metastatic breast cancer. Based at Brisbane’s Translational Research Institute, she was recruited by Mater Research in 2022 to help facilitate patient-focused research at the interface of biomedical R&D and clinical pra …
Matched phrases in profile:
Total Laparoscopic Hysterectomy (TLH) among a total of 760 patients with Endometrial Cancer (EC). LACE… My quality of life research focuses on interventions that can help people with cancer to improve their wellbeing… Quality of life after early enteral feeding versus standard care for proven or suspected advanced epithelial ovarian cancer: Results from a randomised trial… Prevention of cervical cancer… Redesigning skin cancer early detection and care (NHMRC Partnership Project administered by QUT)… Did you know that cervical cancer is one of the most avoidable cancers in the world? Despite… background in cancer prevention and quality of life research, with strong clinical collaborations, and a… Background Malnutrition is common in patients with advanced epithelial ovarian cancer (EOC), and is…
Professor Monika Janda is the Director, Centre for Health Services Research, and Professor in Behavioural Science, at the Faculty of Medicine, University of Queensland, and a recent NHMRC Translational Research Fellow (2018-20). Professor Janda leads the NHMRC Centre for Reserch Excellence in Skin I …
Professor Janda has three main research interests i) prevention and early detection of cancer (in particular melanoma); ii) improving clinical and supportive care for cancer patients (in particular gynaecological cancers), as well as iii) innovative methods of health services delivery and digital in …
Matched phrases in profile:
maximising the utility of specimens for lung cancer genomics when they are collected at biopsy using Endobronchial ultrasound.… advanced non-small cell lung cancer not suitable for radical chemoradiation therapy… Streamlining lung cancer diagnosis through genomic testing of cytology smears… Lung Cancer Genomics… become standard of care for diagnosing lung cancer. My research has been centred on how… therapy with concurrent weekly low-dose gemcitabine in the management of locally advanced non-small cell lung cancer (NSCLC).…
I am a physician at RBWH where I did my undergraduate training. I subspecialised in THoracic Medicine with a focus on bronchoscopy. I helped to create a large interventional service here. Part of that inlcuded instituting endobronchial ultrasound ( EBUS), an Australian first, in 2003. This has becom …
Our work has proposed workflow solutions including use of diff quik smears as alternative samples to formalin base samples for genomic study
Our work has built upon the idea of smears being " what yiou see is what you get" as far as samples for genomics, and the way smear microscopy can predict DNA …
Matched phrases in profile:
. Survivin and XIAP have emerged as attractive targets for cancer therapeutics. This project will… Vincristine pharmacodynamics and pharmacogenetics in children with cancer: A limited-sampling, population modelling approach… Life and health after childhood cancer: a national data linkage cohort study (Cancer Australia grant led by The University of Sydney)… Blood Cancers… local, national and international collaborative research across all childhood cancer types. A/Prof… attractive small molecule targets for cancer therapeutics, with several inhibitors currently in…
Associate Professor Andy Moore is a Paediatric Oncologist and Director of Research at Children's Health Queensland Hospital & Health Service (CHQ). He is also Director of the Queensland Children's Tumour Bank, which is part of UQ's Child Health Research Centre. The Queensland Children's Tumour Bank …
Matched phrases in profile:
Head and neck cancers (HNC) are the 7th most common cancer and account for 2,500 new cases in… Applications in lung, skin, and head and neck cancers.… Transformation or progression from adenocarcinoma to small cell lung cancer detected by serially tracking mutations in the blood… From Pixels to Prognosis: Harnessing single-cell spatial analysis to predict and improve immunotherapy response in lung cancer… approaches in the Asia-Pacific region, contributing to world-first studies for lung cancer, head… cancers (HNCs). Whilst the prognostic and predictive value of single CTCs have been well documented…
Dr Arutha Kulasinghe is a Senior Research Fellow and leads the Clinical-oMx Lab at the University of Queensland. Dr Kulasinghe has pioneered spatial transcriptomics using digital spatial profiling approaches in the Asia-Pacific region, contributing to world-first studies for lung cancer, head and ne …
Matched phrases in profile:
Cancers in Australia in 2010 attributable to infectious agents… Obesity-induced Barrett's oesophagus and associated cancer: mechanisms and diagnostic tools… Obesity and cancer… Professor Bradley Kendall is a clinical academic Gastroenterologist and Cancer Epidemiologist… average risk for developing EAC; these individuals might benefit from targeted cancer-prevention strategies. …
Professor Bradley Kendall is a clinical academic Gastroenterologist and Cancer Epidemiologist. He is currently a Senior Staff Gastroenterologist (Eminent) at the Princess Alexandra Hospital, Brisbane with over 30 years of experience in clinical practice. His clinical training included Fellowships in …
Professor Kendall’s work on the role of obesity in gastrointestinal cancer has been acknowledged nationally and internationally. His work has a strong translational focus contributing to the development of clinical risk prediction tools, national clinical guidelines, and position statements. As an …